Congress
$1,001–$15,000
Traded Oct 29, 2024 · disclosed 318 days laterLateSpouse
4 different filers disclosed BMY within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Mar 31, 2025 (Q1 2025) · Filed Aug 14, 2025
5 tracked managers disclosed the same change for Q1 2025. From a 13F filed Aug 14, 2025 covering holdings at Mar 31, 2025 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Exited
Compared with the manager's Q4 2024 13F
3,188,000
0
−100.0%
Share count drives classification; reported value also moves with price
5
For Q1 2025
Congress
Traded Oct 29, 2024 · disclosed 318 days laterLateSpouse
4 different filers disclosed BMY within 90 days.
Congress
Traded Aug 14, 2025 · disclosed 28 days laterJoint
3 different filers disclosed BMY within 90 days.
David V Elkins (EVP, Chief Financial Officer) sold ~$2.65M of Bristol Myers Squibb
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.